Subconjunctival Injection of Bevacizumab in the Treatment of Corneal Neovascularization Associated With Lipid Deposition (Q59121907)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 January 2011
edit
Language Label Description Also known as
English
Subconjunctival Injection of Bevacizumab in the Treatment of Corneal Neovascularization Associated With Lipid Deposition
scientific article published on 01 January 2011

    Statements

    Subconjunctival injection of bevacizumab in the treatment of corneal neovascularization associated with lipid deposition (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit